Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.
Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
CN 
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA
Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.
Basic Nutrition, your expert for sourcing from China, India and Europe.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]JDMF
Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
Registration Number : 302MF10032
Registrant's Address : Shibuya 1-4-13, Shibuya-ku, Tokyo
Initial Date of Registration : 2020-02-27
Latest Date of Registration : 2020-02-27
Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.
Registration Number : 217MF10551
Registrant's Address : 250 Noda, Noda City, Chiba Prefecture
Initial Date of Registration : 2005-09-09
Latest Date of Registration : 2009-09-24
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
Lead Product(s) : Hyaluronic Acid,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Synvisc-One
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 17, 2015
Lead Product(s) : Hyaluronic Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
SKINVIVE™ by JUVÉDERM® Receives U.S. FDA Approval
Details : Skinvive™ by Juvéderm® is a smooth, injectable HA gel that contains a small amount of local anesthetic (lidocaine). It improves skin quality in the cheeks by smoothing the skin and increasing hydration.
Product Name : Skinvive
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 15, 2023
Lead Product(s) : Hyaluronic Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
JUVÉDERM® VOLUX™ XC For Improvement Of Jawline Definition Now Available Nationwide
Details : Juvederm Voluma™ XC (hyaluronic acid) is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.
Product Name : Juvederm Volux XC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 18, 2023
Lead Product(s) : Hyaluronic Acid,Lidocaine
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye Hollows
Details : JUVÉDERM® VOLBELLA® XC was first FDA–approved in 2016 for use in the lips and perioral rhytids.2 As the category leader, the JUVÉDERM® Collection of Fillers offers the broadest portfolio, and this latest approval marks the sixth approved indicatio...
Product Name : Juvederm Volux XC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 02, 2022
Lead Product(s) : Hyaluronic Acid,HYDROXYPROPYLMETHYLCELLULOSE
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Allergan Aesthetics looks to further develop the Hybrid Injectables category by introducing its first dual-effect product, which combines the two active ingredients - hyaluronic acid, a well-known ingredient found in facial fillers and calcium hydroxyapa...
Product Name : Juvederm Volux XC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 29, 2022
Lead Product(s) : Hyaluronic Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition
Details : JUVÉDERM® VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile in adults over 21.
Product Name : Juvederm Volux XC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 08, 2022
Lead Product(s) : Hyaluronic Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approves JUVÉDERM® VOLUMA™ XC for Enhancement of the Chin Region
Details : JUVÉDERM (Hyaluronic Acid) is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in mid-face and for augmentation of chin region to improve chin profile in adults over age of 2...
Product Name : Juvederm Volux XC
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 15, 2020
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health
Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Product Name : Dermial
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 25, 2022
Lead Product(s) : Hyaluronic Acid,Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Apsen
Deal Size : Undisclosed
Deal Type : Partnership
Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA
Details : Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint...
Product Name : Motilex HA
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 26, 2021
Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Laboratorios Ordesa Incorporates B-2cool®, Bioiberica’s Native Type II Collagen, in Its New Col...
Details : B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
July 15, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Film Formers & Plasticizers
Thickeners and Stabilizers
Coating Systems & Additives
Parenteral
Fillers, Diluents & Binders
Rheology Modifiers
Granulation
Direct Compression
Lubricants & Glidants
Solubilizers
Controlled & Modified Release
Emulsifying Agents
Chewable & Orodispersible Aids
Co-Processed Excipients
API Stability Enhancers
Taste Masking
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
06 Feb 2025
Reply
02 Aug 2024
Reply
01 Aug 2024
Reply
07 May 2024
Reply
25 Oct 2023
Reply
24 Jul 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ANALYTICAL
ABOUT THIS PAGE
54
PharmaCompass offers a list of Hyaluronic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hyaluronic Acid manufacturer or Hyaluronic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hyaluronic Acid manufacturer or Hyaluronic Acid supplier.
PharmaCompass also assists you with knowing the Hyaluronic Acid API Price utilized in the formulation of products. Hyaluronic Acid API Price is not always fixed or binding as the Hyaluronic Acid Price is obtained through a variety of data sources. The Hyaluronic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hyaluronic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyaluronic Acid, including repackagers and relabelers. The FDA regulates Hyaluronic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyaluronic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hyaluronic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hyaluronic Acid supplier is an individual or a company that provides Hyaluronic Acid active pharmaceutical ingredient (API) or Hyaluronic Acid finished formulations upon request. The Hyaluronic Acid suppliers may include Hyaluronic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Hyaluronic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hyaluronic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Hyaluronic Acid active pharmaceutical ingredient (API) in detail. Different forms of Hyaluronic Acid DMFs exist exist since differing nations have different regulations, such as Hyaluronic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hyaluronic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Hyaluronic Acid USDMF includes data on Hyaluronic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hyaluronic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hyaluronic Acid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Hyaluronic Acid Drug Master File in Japan (Hyaluronic Acid JDMF) empowers Hyaluronic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Hyaluronic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of Hyaluronic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Hyaluronic Acid suppliers with JDMF on PharmaCompass.
Hyaluronic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hyaluronic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hyaluronic Acid GMP manufacturer or Hyaluronic Acid GMP API supplier for your needs.
A Hyaluronic Acid CoA (Certificate of Analysis) is a formal document that attests to Hyaluronic Acid's compliance with Hyaluronic Acid specifications and serves as a tool for batch-level quality control.
Hyaluronic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Hyaluronic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hyaluronic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Hyaluronic Acid EP), Hyaluronic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hyaluronic Acid USP).
Comment (1)
